Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis: Implications of JUPITER from the multi-ethnic study of atherosclerosis

Michael J. Blaha, Juan J. Rivera, Matthew J. Budoff, Ron Blankstein, Arthur Agatston, Daniel H. O'Leary, Mary Cushman, Susan Lakoski, Michael H. Criqui, Moyses Szklo, Roger S. Blumenthal, Khurram Nasir

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Objective- High-sensitivity C-reactive protein (hsCRP) levels are closely associated with abdominal obesity, metabolic syndrome, and atherosclerotic cardiovascular disease. The Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial has encouraged using hsCRP ≥2 mg/L to guide statin therapy; however, the association of hsCRP and atherosclerosis, independent of obesity, remains unknown. Methods and Results- We studied 6760 participants from the Multi-Ethnic Study of Atherosclerosis (MESA). Participants were stratified into 4 groups: nonobese/low hsCRP, nonobese/high hsCRP, obese/low hsCRP, and obese/high hsCRP. Using multivariable logistic and robust linear regression, we described the association with subclinical atherosclerosis, using coronary artery calcium (CAC) and carotid intima-media thickness (cIMT). Mean body mass index was 28.3±5.5 kg/m, and median hsCRP was 1.9 mg/L (0.84 to 4.26). High hsCRP, in the absence of obesity, was not associated with CAC and was mildly associated with cIMT. Obesity was strongly associated with CAC and cIMT independently of hsCRP. When obesity and high hsCRP were both present, there was no evidence of multiplicative interaction. Similar associations were seen among 2083 JUPITER-eligible individuals. Conclusion- High hsCRP, as defined by JUPITER, was not associated with CAC and was mildly associated with cIMT in the absence of obesity. In contrast, obesity was associated with both measures of subclinical atherosclerosis independently of hsCRP status.

Original languageEnglish
Pages (from-to)1430-1438
Number of pages9
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume31
Issue number6
DOIs
StatePublished - Jun 1 2011
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Primary Prevention
C-Reactive Protein
Atherosclerosis
Obesity
Carotid Intima-Media Thickness
Coronary Vessels
Calcium
Rosuvastatin Calcium
Linear Models

Keywords

  • coronary artery disease
  • electron beam computed tomography
  • epidemiology
  • obesity
  • vascular biology

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis : Implications of JUPITER from the multi-ethnic study of atherosclerosis. / Blaha, Michael J.; Rivera, Juan J.; Budoff, Matthew J.; Blankstein, Ron; Agatston, Arthur; O'Leary, Daniel H.; Cushman, Mary; Lakoski, Susan; Criqui, Michael H.; Szklo, Moyses; Blumenthal, Roger S.; Nasir, Khurram.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 31, No. 6, 01.06.2011, p. 1430-1438.

Research output: Contribution to journalArticle

Blaha, MJ, Rivera, JJ, Budoff, MJ, Blankstein, R, Agatston, A, O'Leary, DH, Cushman, M, Lakoski, S, Criqui, MH, Szklo, M, Blumenthal, RS & Nasir, K 2011, 'Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis: Implications of JUPITER from the multi-ethnic study of atherosclerosis', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 6, pp. 1430-1438. https://doi.org/10.1161/ATVBAHA.111.223768
Blaha, Michael J. ; Rivera, Juan J. ; Budoff, Matthew J. ; Blankstein, Ron ; Agatston, Arthur ; O'Leary, Daniel H. ; Cushman, Mary ; Lakoski, Susan ; Criqui, Michael H. ; Szklo, Moyses ; Blumenthal, Roger S. ; Nasir, Khurram. / Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis : Implications of JUPITER from the multi-ethnic study of atherosclerosis. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2011 ; Vol. 31, No. 6. pp. 1430-1438.
@article{806e6204c35747bd9df893a19a7d8ce3,
title = "Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis: Implications of JUPITER from the multi-ethnic study of atherosclerosis",
abstract = "Objective- High-sensitivity C-reactive protein (hsCRP) levels are closely associated with abdominal obesity, metabolic syndrome, and atherosclerotic cardiovascular disease. The Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial has encouraged using hsCRP ≥2 mg/L to guide statin therapy; however, the association of hsCRP and atherosclerosis, independent of obesity, remains unknown. Methods and Results- We studied 6760 participants from the Multi-Ethnic Study of Atherosclerosis (MESA). Participants were stratified into 4 groups: nonobese/low hsCRP, nonobese/high hsCRP, obese/low hsCRP, and obese/high hsCRP. Using multivariable logistic and robust linear regression, we described the association with subclinical atherosclerosis, using coronary artery calcium (CAC) and carotid intima-media thickness (cIMT). Mean body mass index was 28.3±5.5 kg/m, and median hsCRP was 1.9 mg/L (0.84 to 4.26). High hsCRP, in the absence of obesity, was not associated with CAC and was mildly associated with cIMT. Obesity was strongly associated with CAC and cIMT independently of hsCRP. When obesity and high hsCRP were both present, there was no evidence of multiplicative interaction. Similar associations were seen among 2083 JUPITER-eligible individuals. Conclusion- High hsCRP, as defined by JUPITER, was not associated with CAC and was mildly associated with cIMT in the absence of obesity. In contrast, obesity was associated with both measures of subclinical atherosclerosis independently of hsCRP status.",
keywords = "coronary artery disease, electron beam computed tomography, epidemiology, obesity, vascular biology",
author = "Blaha, {Michael J.} and Rivera, {Juan J.} and Budoff, {Matthew J.} and Ron Blankstein and Arthur Agatston and O'Leary, {Daniel H.} and Mary Cushman and Susan Lakoski and Criqui, {Michael H.} and Moyses Szklo and Blumenthal, {Roger S.} and Khurram Nasir",
year = "2011",
month = "6",
day = "1",
doi = "10.1161/ATVBAHA.111.223768",
language = "English",
volume = "31",
pages = "1430--1438",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis

T2 - Implications of JUPITER from the multi-ethnic study of atherosclerosis

AU - Blaha, Michael J.

AU - Rivera, Juan J.

AU - Budoff, Matthew J.

AU - Blankstein, Ron

AU - Agatston, Arthur

AU - O'Leary, Daniel H.

AU - Cushman, Mary

AU - Lakoski, Susan

AU - Criqui, Michael H.

AU - Szklo, Moyses

AU - Blumenthal, Roger S.

AU - Nasir, Khurram

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Objective- High-sensitivity C-reactive protein (hsCRP) levels are closely associated with abdominal obesity, metabolic syndrome, and atherosclerotic cardiovascular disease. The Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial has encouraged using hsCRP ≥2 mg/L to guide statin therapy; however, the association of hsCRP and atherosclerosis, independent of obesity, remains unknown. Methods and Results- We studied 6760 participants from the Multi-Ethnic Study of Atherosclerosis (MESA). Participants were stratified into 4 groups: nonobese/low hsCRP, nonobese/high hsCRP, obese/low hsCRP, and obese/high hsCRP. Using multivariable logistic and robust linear regression, we described the association with subclinical atherosclerosis, using coronary artery calcium (CAC) and carotid intima-media thickness (cIMT). Mean body mass index was 28.3±5.5 kg/m, and median hsCRP was 1.9 mg/L (0.84 to 4.26). High hsCRP, in the absence of obesity, was not associated with CAC and was mildly associated with cIMT. Obesity was strongly associated with CAC and cIMT independently of hsCRP. When obesity and high hsCRP were both present, there was no evidence of multiplicative interaction. Similar associations were seen among 2083 JUPITER-eligible individuals. Conclusion- High hsCRP, as defined by JUPITER, was not associated with CAC and was mildly associated with cIMT in the absence of obesity. In contrast, obesity was associated with both measures of subclinical atherosclerosis independently of hsCRP status.

AB - Objective- High-sensitivity C-reactive protein (hsCRP) levels are closely associated with abdominal obesity, metabolic syndrome, and atherosclerotic cardiovascular disease. The Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial has encouraged using hsCRP ≥2 mg/L to guide statin therapy; however, the association of hsCRP and atherosclerosis, independent of obesity, remains unknown. Methods and Results- We studied 6760 participants from the Multi-Ethnic Study of Atherosclerosis (MESA). Participants were stratified into 4 groups: nonobese/low hsCRP, nonobese/high hsCRP, obese/low hsCRP, and obese/high hsCRP. Using multivariable logistic and robust linear regression, we described the association with subclinical atherosclerosis, using coronary artery calcium (CAC) and carotid intima-media thickness (cIMT). Mean body mass index was 28.3±5.5 kg/m, and median hsCRP was 1.9 mg/L (0.84 to 4.26). High hsCRP, in the absence of obesity, was not associated with CAC and was mildly associated with cIMT. Obesity was strongly associated with CAC and cIMT independently of hsCRP. When obesity and high hsCRP were both present, there was no evidence of multiplicative interaction. Similar associations were seen among 2083 JUPITER-eligible individuals. Conclusion- High hsCRP, as defined by JUPITER, was not associated with CAC and was mildly associated with cIMT in the absence of obesity. In contrast, obesity was associated with both measures of subclinical atherosclerosis independently of hsCRP status.

KW - coronary artery disease

KW - electron beam computed tomography

KW - epidemiology

KW - obesity

KW - vascular biology

UR - http://www.scopus.com/inward/record.url?scp=79957456975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957456975&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.111.223768

DO - 10.1161/ATVBAHA.111.223768

M3 - Article

C2 - 21474823

AN - SCOPUS:79957456975

VL - 31

SP - 1430

EP - 1438

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 6

ER -